- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.2: 25 residues within 4Å:- Chain A: H.12, K.16, S.17, F.18, N.19, S.21, P.103, L.104, Y.105, W.106, F.107, T.148, T.149, G.150, G.151, Y.156, E.194, E.198, R.201, K.202, V.205
- Chain B: N.67, Y.68, D.118
- Ligands: 6T2.3
27 PLIP interactions:25 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Y.105, A:Y.105, A:Y.105, B:Y.68
- Hydrogen bonds: A:F.18, A:N.19, A:N.19, A:S.21, A:S.21, A:L.104, A:L.104, A:W.106, A:F.107, A:T.148, A:T.148, A:G.150, A:G.151, A:Y.156, A:Y.156, A:E.194, A:R.201, B:N.67
- Water bridges: A:K.16, A:E.194, A:E.194
- Salt bridges: A:H.12
- pi-Stacking: A:F.107
FAD.4: 25 residues within 4Å:- Chain A: N.67, Y.68, D.118
- Chain B: H.12, K.16, S.17, F.18, N.19, S.21, P.103, L.104, Y.105, W.106, F.107, T.148, T.149, G.150, G.151, Y.156, E.194, E.198, R.201, K.202, V.205
- Ligands: 6T2.6
25 PLIP interactions:23 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:Y.105, B:Y.105, B:Y.105, A:Y.68
- Hydrogen bonds: B:F.18, B:N.19, B:N.19, B:S.21, B:S.21, B:L.104, B:L.104, B:W.106, B:F.107, B:T.148, B:T.148, B:G.150, B:G.151, B:Y.156, B:Y.156, B:R.201, A:N.67
- Water bridges: B:E.194, B:E.194
- Salt bridges: B:H.12
- pi-Stacking: B:F.18
- 2 x 6T2: 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine(Non-covalent)
6T2.3: 14 residues within 4Å:- Chain A: W.106, F.107, G.150, G.151, T.152, M.155, N.162, I.195
- Chain B: L.121, Q.123, F.127, I.129, F.179
- Ligands: FAD.2
10 PLIP interactions:4 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:F.127, B:I.129, B:F.179, A:W.106
- Water bridges: B:Q.123, A:E.194, A:E.194, A:I.195
- Hydrogen bonds: A:N.162
- pi-Stacking: A:W.106
6T2.6: 13 residues within 4Å:- Chain A: Q.123, F.127, I.129, F.179
- Chain B: W.106, G.150, G.151, T.152, M.155, N.162, E.194, I.195
- Ligands: FAD.4
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:F.127, A:F.127, A:F.179, B:W.106
- Hydrogen bonds: B:N.162, B:E.194
- pi-Stacking: B:W.106
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Klaeger, S. et al., The target landscape of clinical kinase drugs. Science (2017)
- Release Date
- 2017-11-29
- Peptides
- Ribosyldihydronicotinamide dehydrogenase [quinone]: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x 6T2: 1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Klaeger, S. et al., The target landscape of clinical kinase drugs. Science (2017)
- Release Date
- 2017-11-29
- Peptides
- Ribosyldihydronicotinamide dehydrogenase [quinone]: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B